Company / Income Tax
Inhibrx Biosciences, Inc. Income Tax History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$2.0K
FY2025
5-year range
$2.0K / $3.0K
FY2023-FY2025
Trend
-33.3%
vs FY2024
Sector context
#115 of 204
Health Care
What the data says
At $2,000, Inhibrx Biosciences, Inc.'s income tax ranks #90 of 204 in the Health Care sector. Improved from $3,000 to $2,000 over the past 2 years.
Based on SEC 10-K filings.
$2,000 in FY2025.
Improved from $3,000 to $2,000 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#90 of 204 in Health CareTop 44% of 204This company $2.0K Sector average $118.7M
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, income tax decreased 33.3% year-over-year.
- Ranks #115 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -3.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.0K | -33.3% |
| FY2024 | $3.0K | +0.0% |
| FY2023 | $3.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026